Share

May 07, 2019; 92 (19) Article

Lipid levels and the risk of hemorrhagic stroke among women

Pamela M. Rist, Julie E. Buring, Paul M Ridker, Carlos S. Kase, Tobias Kurth, Kathryn M. Rexrode
First published April 10, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007454
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
3526

Share

Article Information

vol. 92 no. 19 e2286-e2294
DOI: 
https://doi.org/10.1212/WNL.0000000000007454
PubMed: 
30971484
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received July 25, 2018
  • Accepted in final form January 14, 2019
  • First Published April 10, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Pamela M. Rist, ScD,
    2. Julie E. Buring, ScD,
    3. Paul M Ridker, MD, MPH,
    4. Carlos S. Kase, MD,
    5. Tobias Kurth, MD, ScD* and
    6. Kathryn M. Rexrode, MD, MPH*
  1. Pamela M. Rist, ScD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Charit? ? Universit?tsmedizin Berlin, funding for travel and speaker honoraria

    Editorial Boards:

    1. Stroke, statistical editor, 2016-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHLBI, K01HL128791, Principle investigator, 2016-present NHLBI, R01HL088521, Project director, 2015-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NCMIC Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Julie E. Buring, ScD,
    3. Scientific Advisory Boards:

    1. Husband - Scientific Advisory Board of Pharmavite

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. honorarium from Bayer for presenting Women's Health Study trial results at a symposium at national meeting, 2005

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research support for pills and/or packaging was provided by Bayer HeathCare and the Natural Source Vitamin E Association for the Women's Health Study.

    Research Support, Government Entities:

    1. NIH grants supporting the Women's Health Study

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Paul M Ridker, MD, MPH,
    4. Scientific Advisory Boards:

    1. 1). Corvidia, BioCivi 2). NHLBI

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1). Novartis, Amgen, Jannsen, Merck - consultant

    Editorial Boards:

    1. 1. Circulation Research, AHA 5 years

    Patents:

    1. 1. Patents related to the use of inflammatory biomarkers in cardiovascular disease held by the Brigham and Women's Hospital and licensed to Seimens.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1). Novartis, Amgen, Jannsen, Merck - consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novartis, Kowa, Pfizer - unrelated research grants

    Research Support, Government Entities:

    1. NHLBI, NCI - unrelated research grants

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License fee payments, Technology or Inventions:

    1. 1. Patents related to the use of inflammatory biomarkers in cardiovascular disease held by the Brigham and Women's Hospital and licensed to Seimens.

    Royalty Payments, Technology or Inventions:

    1. 1. Patents related to the use of inflammatory biomarkers in cardiovascular disease held by the Brigham and Women's Hospital and licensed to Seimens.

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Carlos S. Kase, MD,
    5. Scientific Advisory Boards:

    1. Boehringer-Ingelheim

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Boehringer-Ingelheim

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Boehringer-Ingelheim

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Tobias Kurth, MD, ScD* and
    6. Scientific Advisory Boards:

    1. (1) Commercial (Lilly, Newsenselab), for providing methodological advice.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Commercial (Novartis, Daiichi Sankyo), for providing a lecture on neuroepidemiology and research methods

    Editorial Boards:

    1. (1) BMJ, for duties as consulting clinical epidemiology editor.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) The Federal Joint Committee Germany, PI of evaluations (ANNOTeM, TNAMSE, SMARTGEM).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Kathryn M. Rexrode, MD, MPH*
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Invited speaker for the International Magnesium conference in Rome 2017 ($500 to cover travel)

    Editorial Boards:

    1. Neuology and JAMA Internal Medicine editorial advisory boards

    Patents:

    1. NONE

    Publishing Royalties:

    1. Editor, Women and Health 2012 (2016 <600$)

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Quincy Bioscience- review of safety reports on over the counter supplements. Prenatal multivitamin review

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHLBI R01- "risk factors for ischemic stroke" ongoing

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Scientific Board for Tegterra/ Inside Tracker. Stock options only with 0$ worth (no stock currently available- not publicly traded- I think unlikely to be ever stock)

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Preventive Medicine, Department of Medicine (P.M. Rist, J.E.B., P.M Ridker), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Neurology (C.S.K.), Emory University, Atlanta, GA; Institute of Public Health (T.K.), Charité–Universitätsmedizin, Berlin, Germany; and Division of Women's Health, Department of Medicine (K.M.R.), Brigham and Women's Hospital, Boston, MA.
  1. Correspondence
    Dr. Rist prist{at}mail.harvard.edu
View Full Text

Article usage

Article usage: April 2019 to April 2023

AbstractFullPdfSource
Apr 20191041402222Highwire
May 2019168022581003Highwire
Jun 201923575939Highwire
Jul 2019325010045Highwire
Aug 201914583917Highwire
Sep 201912761615Highwire
Oct 20198871510Highwire
Nov 20198342816Highwire
Dec 2019828257Highwire
Jan 20209212421Highwire
Feb 20208891913Highwire
Mar 202059579Highwire
Apr 2020577167Highwire
May 202051122Highwire
Jun 202040354Highwire
Jul 202040555Highwire
Aug 202045951Highwire
Sep 2020112475Highwire
Oct 202073744Highwire
Nov 202041844Highwire
Dec 202042832Highwire
Jan 202144632Highwire
Feb 202145297Highwire
Mar 202156684Highwire
Apr 202160944Highwire
May 2021455102Highwire
Jun 202138552Highwire
Jul 202142622Highwire
Aug 202142824Highwire
Sep 202148731Highwire
Oct 202130882Highwire
Nov 202136252Highwire
Dec 202132566Highwire
Jan 202231665Highwire
Feb 2022243101Highwire
Mar 202240872Highwire
Apr 2022289104Highwire
May 202227272Highwire
Jun 202233042Highwire
Jul 202230813Highwire
Aug 202233341Highwire
Sep 202233721Highwire
Oct 202249425Highwire
Nov 202231165Highwire
Dec 202229330Highwire
Jan 202328643Highwire
Feb 202323940Highwire
Mar 202328520Highwire
Apr 202324223Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Related Articles

Topics Discussed

Alert Me

Recommended articles